AI Image
Popular weight-loss drugs may prevent prediabetes from turning into diabetes
Fox News • • health
Key Points:
- A large observational study found that adults with prediabetes and obesity taking GLP-1-based medications had a 31% lower risk of developing type 2 diabetes and a 41% lower risk of death compared to those on metformin.
- The study, involving 256,492 adults with an average age of 52, also showed GLP-1 medications were linked to fewer strokes (20%), heart attacks (15%), and heart failure cases (25%) over three years.
- Researchers noted the surprising 41% reduction in all-cause mortality and benefits across multiple cardiovascular outcomes, suggesting GLP-1 drugs may be effective during the prediabetes stage, not just after diabetes onset.
- The findings are preliminary and have not undergone full peer review; limitations include potential confounding factors, reliance on electronic health records, and grouping different GLP-1 drugs together.
- Experts recommend that individuals with prediabetes and obesity consult their doctors before making any changes, emphasizing that metformin and lifestyle modifications remain foundational treatments.
